Computed from CROX's own SEC filings (FY2025), benchmarked against ATR and CSL. Every figure is deterministic — no estimates, no AI math — and in the full pack the subject's figures cite their exact SEC filing (tag, form and period), with every company identified by its CIK.
| Metric | CROXFY2025 · 2025-12-31 | ATRFY2025 · 2025-12-31 | CSLFY2025 · 2025-12-31 | Peer med. | Pctile |
|---|---|---|---|---|---|
| Revenue | $4.04B | $3.78B | $5.02B | $4.40B | 50th of 2 |
| Revenue growth (YoY) | -1.5% | 5.4% | 0.3% | 2.9% | 0th of 2 |
| Operating margin | 3.7% | 13.3% | 20.0% | 16.6% | 0th of 2 |
| Net margin | -2.0% | 10.4% | 14.8% | 12.6% | 0th of 2 |
| FCF margin | 16.3% | 7.9% | 19.3% | 13.6% | 50th of 2 |
| Capex % of revenue | 1.3% | 7.2% | 2.6% | 4.9% | 0th of 2 |
| Gross margin | — | — |
| SG&A % · R&D % · tax rate | — | — |
| Net debt/EBITDA · cash-conversion cycle · buybacks | — | — |
Each column is that company's own annual period — its fiscal year and period end are printed in the header. Fiscal calendars differ across companies, so each peer is shown on the annual period ending closest to CROX's 2025-12-31, never a later filing than the subject's own year; a peer with no period within 400 days of it is not published here at all. Green/red = better/worse than the peer median where direction is unambiguous. Percentile = share of these peers at or below CROX's value. The full pack adds up to 12 same-sector peers you choose, up to 17 extended metrics where disclosed, trends for every filed year (up to five), and a provenance table citing the subject's figures to their SEC tag, form and period and identifying every company by its CIK. A subscription covers as many packs as you need, on any covered company, generated on demand; 14-day refund if any figure misstates its cited filing. Informational benchmarking from public SEC data — not investment advice. — Sam, CompsDesk